Recent Advances of Chitosan Nanoparticles As Drug Carriers

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2011 May 19

PMID 21589644

Citations 172

Authors

Jun Jie Wang

Zhao Wu Zeng

Ren Zhong Xiao

Tian Xie

Guang Lin Zhou

Xiao Ri Zhan

Shu Ling Wang

Affiliations

Soon will be listed here.

Abstract

Chitosan nanoparticles are good drug carriers because of their good biocompatibility and biodegradability, and can be readily modified. As a new drug delivery system, they have attracted increasing attention for their wide applications in, for example, loading protein drugs, gene drugs, and anticancer chemical drugs, and via various routes of administration including oral, nasal, intravenous, and ocular. This paper reviews published research on chitosan nanoparticles, including its preparation methods, characteristics, modification, in vivo metabolic processes, and applications.

Citing Articles

Solidified reverse micellar solution-based chitosan-coated solid lipid nanoparticles as a new approach to enhance oral delivery of artemether in malaria treatment.

Kenechukwu F, Ugwu K, Offorbuike C, Ojukwu E, Gugu T, Eze R BMC Chem. 2025; 19(1):64.

PMID: 40057800 PMC: 11890727. DOI: 10.1186/s13065-025-01422-4.

Intranasal Immunization with DNA Vaccine HA-CCL19/Polyethylenimine/Chitosan Composite Provides Immune Protection Against H7N9 Infection.

Xiang Y, Zhang H, An Y, Chen Z Vaccines (Basel). 2025; 13(1).

PMID: 39852789 PMC: 11768641. DOI: 10.3390/vaccines13010010.

Chitosan Nanoparticles, a Novel Drug Delivery System to Transfer Squalene for Hepatocyte Stress Protection.

Bidooki S, Spitzer L, Petitpas A, Sanchez-Marco J, Martinez-Beamonte R, Lasheras R ACS Omega. 2025; 9(52):51379-51393.

PMID: 39758614 PMC: 11696419. DOI: 10.1021/acsomega.4c08258.

Synthesis of chitosan nanoparticles (CSNP): effect of CH-CH-TPP ratio on size and stability of NPs.

Des Bouillons-Gamboa R, Montes de Oca G, Baudrit J, Rios Duarte L, Lopretti M, Renteria Urquiza M Front Chem. 2024; 12:1469271.

PMID: 39618968 PMC: 11604443. DOI: 10.3389/fchem.2024.1469271.

Loratadine Loaded Chitosan Tannic Acid Nanoparticles as Anti-Proliferative Agent Against Breast Cancer: In-silico, in-vitro and Cell Studies.

Ali I, Al-Tabakha M, Khalil I Int J Nanomedicine. 2024; 19:12483-12504.

PMID: 39600410 PMC: 11590658. DOI: 10.2147/IJN.S483667.

References

Liu X . [Chitosan-siRNA complex nanoparticles for gene silencing]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2010; 27(1):97-101. View

Katas H, Alpar H . Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release. 2006; 115(2):216-25. DOI: 10.1016/j.jconrel.2006.07.021. View

Amidi M, Mastrobattista E, Jiskoot W, Hennink W . Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev. 2009; 62(1):59-82. DOI: 10.1016/j.addr.2009.11.009. View

Yin L, Ding J, He C, Cui L, Tang C, Yin C . Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials. 2009; 30(29):5691-700. DOI: 10.1016/j.biomaterials.2009.06.055. View

Bodnar M, Hartmann J, Borbely J . Preparation and characterization of chitosan-based nanoparticles. Biomacromolecules. 2005; 6(5):2521-7. DOI: 10.1021/bm0502258. View

Kim J, Kim Y, Kim S, Park J, Kim K, Choi K . Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. J Control Release. 2006; 111(1-2):228-34. DOI: 10.1016/j.jconrel.2005.12.013. View

Goldberg M, Langer R, Jia X . Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed. 2007; 18(3):241-68. PMC: 3017754. DOI: 10.1163/156856207779996931. View

Chung J, Yokoyama M, Yamato M, Aoyagi T, Sakurai Y, Okano T . Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate). J Control Release. 1999; 62(1-2):115-27. DOI: 10.1016/s0168-3659(99)00029-2. View

Maeda Y, Kimura Y . Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice. J Nutr. 2004; 134(4):945-50. DOI: 10.1093/jn/134.4.945. View

10.

Xu X, Zhou J, Li L, Zhang Y, Huo M, Wang X . [Preparation of doxorubicin-loaded chitosan polymeric micelle and study on its tissue biodistribution in mice]. Yao Xue Xue Bao. 2008; 43(7):743-8. View

11.

Lavertu M, Methot S, Tran-Khanh N, Buschmann M . High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials. 2006; 27(27):4815-24. DOI: 10.1016/j.biomaterials.2006.04.029. View

12.

Huo M, Zhang Y, Zhou J, Zou A, Yu D, Wu Y . Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug. Int J Pharm. 2010; 394(1-2):162-73. DOI: 10.1016/j.ijpharm.2010.05.001. View

13.

Nam H, Kwon S, Chung H, Lee S, Kwon S, Jeon H . Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J Control Release. 2009; 135(3):259-67. DOI: 10.1016/j.jconrel.2009.01.018. View

14.

Zhang N, Li J, Jiang W, Ren C, Li J, Xin J . Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles. Int J Pharm. 2010; 393(1-2):212-8. DOI: 10.1016/j.ijpharm.2010.04.006. View

15.

Kim D, Jeong Y, Choi C, Roh S, Kang S, Jang M . Retinol-encapsulated low molecular water-soluble chitosan nanoparticles. Int J Pharm. 2006; 319(1-2):130-8. DOI: 10.1016/j.ijpharm.2006.03.040. View

16.

Wedmore I, McManus J, Pusateri A, Holcomb J . A special report on the chitosan-based hemostatic dressing: experience in current combat operations. J Trauma. 2006; 60(3):655-8. DOI: 10.1097/01.ta.0000199392.91772.44. View

17.

Yuan Q, Shah J, Hein S, Misra R . Controlled and extended drug release behavior of chitosan-based nanoparticle carrier. Acta Biomater. 2009; 6(3):1140-8. DOI: 10.1016/j.actbio.2009.08.027. View

18.

Jones R, Cheung C, Black F, Zia J, Stayton P, Hoffman A . Poly(2-alkylacrylic acid) polymers deliver molecules to the cytosol by pH-sensitive disruption of endosomal vesicles. Biochem J. 2003; 372(Pt 1):65-75. PMC: 1223370. DOI: 10.1042/BJ20021945. View

19.

Min K, Park K, Kim Y, Bae S, Lee S, Jo H . Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J Control Release. 2008; 127(3):208-18. DOI: 10.1016/j.jconrel.2008.01.013. View

20.

Bravo-Osuna I, Vauthier C, Farabollini A, Palmieri G, Ponchel G . Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. Biomaterials. 2007; 28(13):2233-43. DOI: 10.1016/j.biomaterials.2007.01.005. View